O-I Glass to Present at Wells Fargo 2025 Industrials and Materials Conference GlobeNewswire June 04, 2025 PERRYSBURG, Ohio, June 04, 2025 (GLOBE NEWSWIRE) — O-I Glass, Inc. (“O-I Glass” or “O-I”) today announced the Company will participate in Wells Fargo's 2025 Industrials and Materials Conference on Wednesday, June 11, 2025. O-I Glass Chief Financial Officer […]
Gaia to Present at Sidoti Virtual Investor Conference June 11-12 GlobeNewswire June 04, 2025 BOULDER, Colo., June 04, 2025 (GLOBE NEWSWIRE) — Gaia, Inc. (NASDAQ: GAIA) (“Gaia” and/or the “Company”), a conscious media and community company, will present and host one-on-one meetings with investors at the Sidoti June Virtual Investor Conference, taking place on June
Superior Group of Companies to Participate in the Sidoti June Investor Conference GlobeNewswire June 04, 2025 ST. PETERSBURG, Fla., June 04, 2025 (GLOBE NEWSWIRE) — Superior Group of Companies, Inc. (NASDAQ: SGC) today announced that Chairman, President and Chief Executive Officer, Michael Benstock, and Chief Financial Officer, Mike Koempel, will participate in a fireside chat
Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference GlobeNewswire June 04, 2025 SOUTH SAN FRANCISCO, Calif., June 04, 2025 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with cancer, announced today that members of its senior management team will
XPO Provides North American LTL Operating Data for May 2025 GlobeNewswire June 04, 2025 GREENWICH, Conn., June 04, 2025 (GLOBE NEWSWIRE) — XPO (NYSE: XPO), a leading provider of freight transportation in North America, today reported certain preliminary LTL segment operating metrics for May 2025. LTL tonnage per day decreased 5.7%, as compared with May
Vera Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference GlobeNewswire June 04, 2025 BRISBANE, Calif., June 04, 2025 (GLOBE NEWSWIRE) — Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced that the Company's management team
89bio to Participate in Goldman Sachs 46th Annual Global Healthcare Conference GlobeNewswire June 04, 2025 SAN FRANCISCO, June 04, 2025 (GLOBE NEWSWIRE) — 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that
NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) — In a new briefing from bestselling author and tech entrepreneur James Altucher, startling revelations are emerging about Musk's most ambitious AI undertaking yet — a project known as “Project Colossus.” According to Altucher, this facility — now operational in Memphis — will soon power what he calls
(TSX-V:NRX),(Frankfurt:J90),(Boerse Stuttgart – Freiverkehr:J90),(Boerse Muenchen – Freiverkehr:J90),(OTC US:NRXBF),(Other OTC:NRXBF), TORONTO and HAIFA, Israel, June 04, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company“) is pleased to announce that on May 22, 2025, it presented new manufacturing process data at the 4th annual meeting of the Israeli
“The AI Mothership Has Landed”: Legendary Tech Investor Reveals Musk's Most Powerful Project Yet From a secret warehouse in Tennessee, Elon Musk is building a machine unlike anything the world has ever seen — and it may change America forever GlobeNewswire June 04, 2025 NEW YORK, June 04, 2025 (GLOBE NEWSWIRE) — In a new